Estudios originales
Published on 23 de enero de 2025 | http://doi.org/10.5867/medwave.2025.01.2946
Surgical outcomes, survival and prognostic factors in a cohort of lung cancer patients operated at the University of Chile Clinical Hospital
Back to article
Univariate analysis of prognostic factors for survival.
| Gender | Female | 1 | |
| Male | 2.01 (1.24 to 3.25) | 0.005 | |
| Age (years) | 1.03 (1.01 to 1.06) | 0.012 | |
| Histology | Adenocarcinoma | 1 | |
| Low grade carcinoid | 0.21 (0.029 to 1.56) | 0.128 | |
| Squamous | 2.4 (1.38 to 4.04) | 0.002 | |
| Undifferentiated | 3.97 (2.01 to 7.84) | < 0.0005 | |
| Stage | Stage 0 or 1 | 1 | |
| Stage 2 | 2.16 (1.2 to 3.92) | 0.011 | |
| Stage 3 or 4 | 2.46 (1.34 to 4.53) | 0.004 | |
| Regional dissemination | N0 | 1 | |
| N1 | 2.37 (1.41 to 3.98) | 0.001 | |
| N2 o N3 | 3.12 (1.44 to 6.77) | 0.004 | |
| Complications | No | 1 | |
| Yes | 2.35 (0.42 to 3.88) | 0.001 |
CI, confidence interval.HR, hazard ratio.
Data from patients operated on for lung cancer. HR for age is interpreted as an increase in risk for each additional year.
Source: Prepared by the authors based on the study results.